TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
CompletedPhase 3

Glutamate for Metabolic Intervention in Coronary Surgery II

The aim of GLUTAMICS II is to evaluate whether intravenous glutamate infusion surgery reduces the risk of postoperative heart failure as measured by plasma NT-proBNP in patients undergoing moderate to high-risk coronary artery bypass graft

Gothenburg, Sweden+3 moreView details
CompletedN/A

Impact of Advance Care Planning on Care for Patients With Advanced Heart Failure

Aims: Advance care planning (ACP) is considered to be one of the most promising interventions to enable patients with life limiting illnesses to receive treatment at the end of life (EOL) according to their own preferences and to promote EO

Singapore, Singapore+1 moreView details
UnknownN/A

Clinical Trial of Autologous Adipose Tissue Derived Stromal Cell Therapy for Ischemic Heart Failure

Mesenchymal stem cells have capability to differentiate into myocardium, vascular endothelial cell, vascular smooth muscle cell and will be useful for heart regeneration. Adipose tissue is relatively enriched with mesenchymal stem cell comp

Kanazawa, Ishikawa-ken, JapanView details
UnknownPhase 4

Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides, Angiotensin and Neprilysin

The study measure multiple neurohormones in patients with heart failure being treated with Sacubitril/Valsartan in increasing doses over an 8 week period.

Hønefoss, Buskerud, NorwayView details
CompletedPhase 3

Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.

This study will evaluate the effect of dapagliflozin versus placebo, given once daily in addition to Standard of Care (SoC) therapies for patients with myocardial infarction (MI), for hospitalisation for heart failure (HHF), cardiovascular

Alingsås, Sweden+102 moreView details
Recruiting

Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence

The aim of this study is to evaluate feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. Several components will be assessed such as quality-of-life, nutritional counseling, maximu

Brookfield, Connecticut, United StatesView details
CompletedPhase 4

Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients

In cancer patients, the increase of troponin I soon after chemotherapy is a strong predictor of left ventricular dysfunction and poor cardiologic outcome. This information provides a rationale for the development of prophylactic strategies

Milan, ItalyView details
Completed

2 New Measurements Used to Describe the Filling Phase of the Left Ventricle (LV).

As we live longer our population experiencing heart failure (HF) continues to grow consuming an increasing percent of healthcare dollars. Systolic heart failure or pump failure is easy to recognize and measure and is expressed as ejection f

Orlando, Florida, United StatesView details
Completed

Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM

Liver biopsy for the assessment of fibrosis has multiple limitations. Liver ShearWaveTM Elastography may provide a non-invasive, fast, and reproducible alternative for the quantitative assessment of liver fibrosis.

Dallas, Texas, United StatesView details
CompletedN/A

Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure

The dose for intravenous administration of OPC-61815 achieving tolvaptan exposure equivalent to that for oral administration of tolvaptan 15-mg tablet will be investigated by administering OPC-61815 injection 2 to 16mg or tolvaptan 15-mg or

Kanto, JapanView details
Unknown

incidenCe and predictOrs of heaRt fAiLure After Acute coronarY Syndrome: CORALYS

Single-cohort retrospective study evaluating the incidence and prognostic markers of heart failure following acute coronary syndrome treated by percutaneous coronary intervention

Torino, ItalyView details
By invitation

Gut Microbiome Profiling in Patients With Chronic Heart Failure

The goal of this observational study is to learn about the composition and function of the gut microbiome in adults with chronic heart failure with reduced ejection fraction. The main questions the study aims to answer are: 1.

Stanford, California, United StatesView details
UnknownN/A

SynCardia 70cc TAH-t for Destination Therapy (DT)

The SynCardia 70cc temporary Total Artificial Heart (TAH-t) is approved by the U.S. Food and Drug Administration (FDA) for use as a bridge to transplant for patients at risk of imminent (about to happen) death from irreversible biventricula

Phoenix, Arizona, United States+6 moreView details
Unknown

Optoelectronic Pletysmography and Diaphragmatic Thickness in Heart Failure Patients

The investigators aimed to evaluate the effects of cardiomegaly associated with inspiratory muscle weakness on tricompartmental distribution of chest wall volumes, on the thickness of the right hemidiaphragm and on the contraction speed of

Recife, Pernambuco, BrazilView details
CompletedN/A

Influence of Angiotensin Converting Enzyme (ACE) Genotype on Lung Diffusion in Heart Failure

In patients with chronic heart failure ACE-inhibitor treatment improves lung diffusion and prevents pulmonary edema after fluid overload. In the western country, 3 population types of ACE genotypes exist (DD, ID, II).

Milan, ItalyView details
RecruitingN/A

Care Transitions App for Patients With Multiple Chronic Conditions

The objective of this study is to widely implement and evaluate the Care Transitions App in a randomized controlled trial. The app the investigators designed for patients with multiple chronic conditions has four envisioned modules: 1) fall

Boston, Massachusetts, United StatesView details
TerminatedN/A

Massage Therapy for Self-efficacy in LVAD Recipients

This pilot study evaluates the role of massage therapy to improve self-efficacy in patients with advanced heart failure who have recently received a left-ventricular assist device. In addition to usual care, half of the volunteer patients w

Washington D.C., District of Columbia, United StatesView details
TerminatedPhase 3

INcrease Of VAgal TonE in CHF

The purpose of the INOVATE-HF study is to demonstrate the long-term safety and efficacy of vagus nerve stimulation with the CardioFit® system for the treatment of subjects with Heart Failure.

Birmingham, Alabama, United States+86 moreView details
CompletedN/A

Atrial Fibrillation (AF) Clinic to Improve the Treatment of Patients With Atrial Fibrillation.

* Randomized controlled trial comparing specialized AF Clinic with 'care as usual' * Hypothesis: treatment of AF patients in the AF-Clinic by a nurse, specialised in AF, using guideline-based dedicated software, under supervision of a cardi

Groningen, Netherlands+1 moreView details
Completed

Prognostic Value of Estimated Plasma Volume in Pulmonary Hypertension

Assessment of the prognostic value of the estimation of plasma volume or its variation in patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) after acute right heart failure.

Multiple locationsView details
Load more trials